Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Samuel Lifshitz is active.

Publication


Featured researches published by Samuel Lifshitz.


Obstetrics & Gynecology | 1998

Pathology slide review in gynecologic oncology.

Joseph T. Santoso; Robert L. Coleman; Richard L. Voet; Steven G. Bernstein; Samuel Lifshitz; David Miller

Objective To analyze the diagnostic accuracy and alteration in treatment planning from interinstitution (different institution) pathologic consultation. Methods We reviewed pathologic reports from 720 referred patients. The diagnosis rendered from a gynecologic pathologist was compared with the original diagnosis. Discrepancies were coded as none, minor, or major. A discrepancy was major if it led to treatment alteration. A discrepancy was minor if it did not lead to treatment alteration. The judgment to declare a discrepancy was made by a gynecologic pathologist, a gynecologist, and three gynecologic oncologists. The review cost was


International Journal of Gynecological Pathology | 1985

Mucin production in defining mixed carcinoma of the uterine cervix: a clinicopathologic study.

Jo Ann Benda; Charles E. Platz; Herbert J. Buchsbaum; Samuel Lifshitz

150 per case. The Cochran Mantel-Haenszel test evaluated any systematic pattern in discrepancies. Results Seven hundred twenty specimens consisted of 113 vulvar, 170 uterine, 289 cervical, 105 ovarian, and 43 vaginal tissues. Six hundred one (84%) pathologic diagnoses showed no discrepancy. There were 104 (14%) minor and 15 (2%) major discrepancies. After reviewing 15 major discrepancies, six surgeries were canceled, two surgeries were modified, one adjuvant radiation treatment was added, one chemotherapy treatment was modified, and five adjuvant chemotherapy treatments were cancelled. No systematic error was identified with regard to the sources (tissue origin) or methods of obtaining the specimen (P = .675). The cost of reviewing 720 specimens was


Anti-Cancer Drugs | 1996

Remission of refractory gestational trophoblastic disease with high-dose paclitaxel.

Wichai Termrungruanglert; Andrzej P. Kudelka; Surintip Piamsomboon; Claire F. Verschraegen; Creighton L. Edwards; Samuel Lifshitz; Rosario Mante; Jonh J Kavanagh

108,000. The cost of identifying each major discrepancy was


American Journal of Obstetrics and Gynecology | 1983

Adenoid cystic carcinoma of Bartholin’s gland

Steven G. Bernstein; Richard L. Voet; Samuel Lifshitz; Herbert J. Buchsbaum

7200. Conclusion Reviewing pathology slides before definitive treatment reveals notable discrepancies in diagnoses. The cost of pathology review is globally expensive but has consequential impact on proper treatment planning for the individual patient.


International Journal of Gynecological Pathology | 1982

Primary Clear Cell Adenocarcinoma of the Fallopian Tube: Light Microscopic and Ultrastructural Findings

Richard L. Voet; Samuel Lifshitz

SummaryEighty-seven Stage I cervical carcinomas treated by radical hysterectomy between 1970 and 1979 were reviewed for histotogic type, outcome, and factors predicting behavior. Initially, the cases were histologically classified by the Wentz and Reagan system and graded according to the Broders method. Stains for intracellular mucin were then examined in 69 cases and 39% were shown to contain intracellular mucin. Using intracellular mucin as an indicator of mixed carcinoma, this study showed a distribution of 35% keratinizing, 16% nonkeratinizing, 3% small cell, 16% adeno-, 3% undiffer-entiated, and 26% mixed carcinoma. The mixed carcinomas were derived from the traditional keratinizing, nonkeratinizing and small cell categories. Mixed carcinoma was the only histologic type that predicted lymph node metastasis (p = 0.009). The presence of lymph node metastasis predicted death due to disease or recurrence (p = 0.014} as did pure adenocarcinoma histology (p = 0.025). Overall 5 year survival was 92%. Survival at 5 years for adenocarcinoma was 85%, but one additional death occurred at 12 years and a first recurrence occurred at 7 years. An additional patient with a collision tumor (adenocarcinoma and squamous carcinoma) died at 8 years. Mixed carcinoma is relatively common and appears to be associated with a higher incidence of lymph node metastasis. Adenocarcinoma appears to have a poorer prognosis and a tendency for late recurrence in distant sites.


American Journal of Obstetrics and Gynecology | 1985

Prevalence of papillomavirus infection in colposcopically directed cervical biopsy specimens in 1972 and 1982

Steven G. Bernstein; Richard L. Voet; David S. Guzick; J.Thomas Melancon; Lynda Ronan-Cowen; Samuel Lifshitz; Herbert J. Buchsbaum

High-risk metastatic gestational trophoblastic disease (GTD) in patients who have failed primary chemotherapy has a very poor prognosis. About 25% of women with high-risk metastatic disease become refractory to EMA-CO (etoposide, methotrexate, actinomycin-D, cyclophosphamide and vincristine) and fall to achieve a complete remission. Currently, there is no standard salvage chemotherapeutic regime for EMA-CO failure. Paclitaxel, a taxane analog extracted from the bark of the western yew (Taxus brevlfolla), has shown antitumor activity in a variety of cancer cell lines. High in vivo efficacy was confirmed in phase II trials, especially for breast and epithelial ovarian cancer patients. Recently, two in vitro studies have shown that paclitaxel is a highly effective antineoplastic agent in choriocarcinoma cell lines. We present the first clinical report of a serologic remission with high-dose paclitaxel (250 mg/m2 i.v. infusion over 24 h every 3 weeks) of a highly refractory GTD in a patient who developed brain metastasis after multiple combined chemotherapeutic regimens. The patient tolerated paclitaxel with granulocyte colony stimulating factor support very well. The remission with paclitaxel in this patient confirms its preclinical activity in high-risk, refractory GTD.


International Journal of Radiation Oncology Biology Physics | 1984

Effect of radiation on prostaglandin production by human bowel in vitro.

David Gal; Daniel M. Strickland; Samuel Lifshitz; Herbert J. Buchsbaum; Murray D. Mitchell

A patient with adenoid cystic carcinoma of Bartholins gland is reported and the literature relevant to this disease reviewed. The clinical presentation is characterized by a vulvar mass that has existed for a prolonged period prior to the onset of symptoms, usually infection, pain, and burning. Histologically the tumor is characterized by a cribriform pattern and perineural invasion. Electron microscopy confirms the epithelial nature of this lesion. Conclusions concerning therapy are presented, including emphasis on initial radical vulvectomy and the fact that the efficacy of routine lymphadenectomy and adjuvant radiotherapy has not been demonstrated.


Archive | 1983

Adenocarcinoma of the Endometrium

Samuel Lifshitz; Steven G. Bernstein

The first reported case of primary clear cell adenocarcinoma of the fallopian tube is presented. The patient, a 52-year-old female, was post-menopausal and presented with anemia and a pelvic mass. The presence of this histologic type in the fallopian tube is consistent with the mullerian origin of this tumor.


Gynecologic Oncology | 1986

Vicryl mesh in pelvic floor reconstruction

Herbert J. Buchsbaum; Wayne Christopherson; Samuel Lifshitz; Steven G. Bernstein

A total of 1264 consecutive cervical biopsy specimens obtained at the Parkland Memorial Hospital Dysplasia Clinic during 1972 were reviewed. Histopathologic specimens were assessed with special reference to changes induced by human papillomavirus. In 1972, only 0.7% of biopsy specimens were reported as consistent with human papillomavirus infection. Upon review, however, 36.5% of these specimens were found to demonstrate histologic criteria for the diagnosis of human papillomavirus infection. Approximately half of biopsy specimens reclassified as human papillomavirus were originally interpreted as inflammation; the others were interpreted as cervical intraepithelial neoplasia. Patients with human papillomavirus infection were significantly younger than patients with cervical intraepithelial neoplasia (24.9 versus 30.2 years). These findings were compared with 965 cervical biopsy specimens obtained in 1982. Thirty-four percent of these biopsy specimens revealed human papillomavirus infection. These observations support the concept that human papillomavirus infection of the cervix is not a new entity but a previously unrecognized finding whose prevalence has been relatively stable over a 10-year period.


Gynecologic Oncology | 1984

Pigskin xenograft as biological dressing in radical vulvectomy

Samuel Lifshitz; Herbert J. Buchsbaum

The effect of gamma irradiation on the production of prostaglandins by human colon was investigated. Squares of tissue in organ culture dishes were irradiated with 500, 1000, or 2500 rad in single applications. Tissues that were not irradiated served as controls. After treatment the tissues were superfused and prostaglandin concentrations in the effluent fluid were determined. The rates of production of prostaglandins E2 and F2 alpha by irradiated tissues were significantly lower (p less than 0.05) than those of nonirradiated tissues. Neither the release of lactate dehydrogenase nor the rate of production of 13,14-dihydro-15-keto-prostaglandin F2 alpha were increased in the irradiated samples, suggesting that neither decreased cell viability nor increased prostaglandin metabolism accounted for the decreased prostaglandin production rates. We conclude that irradiation of the human colon in vitro results in an acute inhibition of prostaglandin synthesis. The cytoprotective nature of prostaglandins is discussed with regard to the possible pathophysiological significance of these findings.

Collaboration


Dive into the Samuel Lifshitz's collaboration.

Top Co-Authors

Avatar

Herbert J. Buchsbaum

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Steven G. Bernstein

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Richard L. Voet

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert L. Coleman

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Andrzej P. Kudelka

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph T. Santoso

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Rosario Mante

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge